Ed Silverman, the Wall Street Journal reporter who runs the Pharmalot blog that covers the drug industry, is joining the Boston Globe.
With the Globe, Silverman will be joining the Globe’s new health care news called Stat that debuts in the fall. He’ll be taking Pharmalot with him and writing a weekly column, too.
Silverman had been laid off from the Journal last month.
Silverman had been hired by the Journal in February 2014 and revived the Pharmalot blog, which he had started while working at the Newark Star-Ledger.
Silverman’s work covering pharma is well known. He wrote a three-part series about allegations that Pfizer sales reps were encouraged to use inappropriate practices to boost sales of an older AIDS drug, which was honored by the Association of Health Care Journalists.
He also broke stories about use of a corporate helicopter by a Pfizer executive to commute from an out-of-state home; FDA plans to boost inspections in China; and a paper co-authored by an FDA staffer that questioned the safety of a widely used diabetes pill — before it was published in JAMA.
Silverman also worked at New York Newsday and Investor’s Business Daily.
He has a master’s degree in journalism from New York University and a bachelor’s in accounting from Binghamton University.
